EFM
COGT icon

E Fund Management’s Cogent Biosciences COGT Stock Holding History

E Fund Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Buy
+16,104
New +$595K 0.02% 238
2025
Q2 		$73.3K Sell
10,205
-5,465
-35% -$30.3K ﹤0.01% 382
2025
Q1 		$93.9K Buy
15,670
+4,290
+38% +$33.6K ﹤0.01% 384
2024
Q4 		$88.8K Buy
+11,380
New +$113K ﹤0.01% 381
2024
Q3 		– Sell
-11,173
Closed -$94.2K – 359
2024
Q2 		$94.2K Sell
11,173
-22,135
-66% -$168K 0.01% 305
2024
Q1 		$224K Buy
33,308
+17,897
+116% +$111K 0.01% 324
2023
Q4 		$90.6K Buy
+15,411
New +$118K 0.01% 304
2023
Q3 		– Sell
-11,088
Closed -$131K – 299
2023
Q2 		$131K Sell
11,088
-2,661
-19% -$30.5K 0.01% 292
2023
Q1 		$148K Sell
13,749
-3,226
-19% -$41.3K 0.01% 311
2022
Q4 		$196K Buy
16,975
+2,585
+18% +$32K 0.02% 306
2022
Q3 		$215K Buy
+14,390
New +$197K 0.02% 294

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

E Fund Management's COGT Position: Q1 2026 in Review

E Fund Management opened a new position in Cogent Biosciences (COGT) in Q1 2026: 16,104 shares worth $620K. The stake represents 0.02% of the portfolio and ranks #238 among its holdings. This is a return to the name: E Fund Management previously reported a position in COGT as recently as Q2 2025.

E Fund Management first reported a position in COGT in Q3 2022 and has held it in 11 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • E Fund Management held 16,104 shares of Cogent Biosciences worth $620K as of Q1 2026.
  • Cogent Biosciences was a new E Fund Management position in Q1 2026.
  • Cogent Biosciences made up 0.02% of E Fund Management's portfolio in Q1 2026, its #238 holding.
  • E Fund Management first reported a position in Cogent Biosciences in Q3 2022 and has held it in 11 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.